infecti
agent
long
implic
pathogenesi
system
lupu
erythematosu
common
virus
epsteinbarr
viru
transfus
transmit
viru
parvoviru
cytomegaloviru
increas
preval
patient
system
lupu
erythematosu
may
contribut
diseas
pathogenesi
trigger
autoimmun
via
structur
function
molecular
mimicri
encod
protein
induc
crossreact
immun
respons
self
antigen
modul
antigen
process
activ
apoptosi
b
cell
macrophag
dendrit
cell
altern
infecti
agent
malaria
toxoplasma
gondii
helicobact
pylori
may
protect
effect
vaccin
may
play
dual
role
protect
friend
foe
alik
system
lupu
erythematosu
sle
system
autoimmun
diseas
mechan
aberr
immun
respons
remain
unclear
sever
environment
factor
implic
etiolog
sle
concord
rate
monozygot
twin
sle
indic
discord
rate
contribut
environment
factor
possibl
viral
etiolog
rais
find
virionlik
tubuloreticular
structur
endotheli
cell
lymphocyt
demonstr
increas
concentr
type
interferon
ifn
lupu
patient
mani
virus
implic
etiolog
sle
includ
epsteinbarr
viru
ebv
transfusiontransmit
viru
tissu
transplant
viru
torqu
tenoviru
retrovirus
paramyxoviru
cytomegaloviru
cmv
parvoviru
corona
viru
tabl
ebv
retrovirus
parvoviru
may
play
role
pathogenesi
sle
compar
virus
cmv
transfus
transmit
viru
type
c
oncorna
viru
measl
viru
play
minor
role
immunodefici
defici
may
predispos
lupu
infect
without
two
directli
link
infecti
agent
may
induc
autoimmun
diseas
sever
mechan
molecular
mimicri
may
structur
function
structur
molecular
mimicri
occur
viral
peptid
amino
acid
sequenc
similar
ident
amino
acid
sequenc
self
peptid
result
crossreact
tcell
bcell
respons
potenti
autoreact
cell
possess
tcell
receptor
recogn
foreign
viral
peptid
selfpeptid
activ
virusderiv
peptid
thu
addit
mediat
antivir
respons
cell
also
capabl
mediat
selfdirect
respons
peptid
sequenc
common
viru
eg
ebv
protein
target
lupu
autoantigen
eg
smith
antigen
sm
also
induc
crossreact
autoantibodi
wide
rang
structur
function
immunolog
similar
envelop
protein
host
protein
tat
gene
upregul
produc
function
mimicri
tat
gene
stimul
transcript
activ
promot
via
transactiv
long
termin
repeat
coordin
upregul
downregul
express
hivinfect
peripher
blood
mononuclear
cell
cell
enhanc
express
may
contribut
downregul
recycl
cell
surfac
thu
prevent
infect
protect
virusinfect
cell
death
cytotox
cell
ebv
protein
regul
apoptosi
encod
protein
hi
fragment
h
rightward
open
read
frame
also
exampl
function
mimicri
figur
exogen
stimuli
product
bacteria
virus
term
pathogenassoci
molecular
pattern
pamp
dendrit
cell
recogn
pamp
use
pathogen
recognit
receptor
tolllik
receptor
tlr
necrot
debri
cell
death
pathway
bacteri
lipopolysaccharid
viral
rna
viral
dna
act
tlr
subset
dendrit
cell
plasmacytoid
dendrit
cell
pdc
bodi
major
produc
type
ifn
ifn
import
host
defens
virus
overproduct
ifn
sle
tlr
activ
pdc
lead
releas
turn
lead
releas
proinflammatori
cytokin
result
autoimmun
result
matur
antigen
present
cell
augment
tcell
activ
includ
excess
helper
activ
natur
killer
cell
produc
signific
amount
cytokin
exampl
influenc
develop
cell
virus
may
affect
innat
immun
releas
proinflammatori
cytokin
protein
commonli
occur
virus
could
produc
profound
effect
cytokin
milieu
antigen
recognit
lymphocyt
cell
surviv
pamp
play
fundament
role
earli
recognit
sever
infecti
agent
gramposit
gramneg
bacteria
rna
dna
virus
molecul
includ
bacteri
cell
surfac
lipopolysaccharid
lipoprotein
protein
flagellin
bacteri
flagella
viral
dsrna
unmethyl
cpg
island
bacteri
viral
dna
sens
type
tlr
pattern
recognit
receptor
figur
least
tlr
recogn
human
recogn
ssrna
bind
dsdna
cpg
motif
bacteri
dna
serv
receptor
peptidoglycan
bacteri
lipoprotein
gramneg
lipopolysaccharid
flagellin
tlr
bind
dna
rna
lead
product
larg
amount
mostli
deriv
plasmacytoid
dendrit
cell
anim
model
lupu
nephriti
tlr
specif
immunoloc
kidney
suggest
possibl
pathogenet
role
manifest
diseas
microbi
stimul
tlr
lead
initi
signal
loop
via
activ
receptorassoci
kinas
irak
tnf
receptorassoci
factor
kinas
ikk
complex
activ
activ
receptor
also
signal
via
tlr
pathway
compon
produc
molecular
mimicri
immunomodul
viral
protein
may
account
crossreact
autoantigen
abnorm
tand
bcell
function
autoimmun
disord
necrot
late
apoptot
cell
releas
materi
combin
immunoglobulin
sle
patient
induc
product
pdc
infect
inhibit
develop
autoimmun
diseas
sever
mechan
infect
elicit
respons
decreas
host
respons
therebi
limit
target
tissu
injuri
interact
molecul
deriv
bacteria
fungi
parasit
tlr
ctype
lectin
receptor
cell
innat
adapt
immun
system
enabl
modul
host
immun
respons
anim
studi
demonstr
exposur
infecti
agent
product
deriv
inhibit
onset
autoimmun
disord
varieti
mechan
includ
reinforc
regulatori
network
influenc
traffick
autoreact
cell
site
inflamm
meticul
exclus
infect
essenti
patient
sle
sinc
infect
may
masquerad
flareup
diseas
immunosuppress
medic
use
treat
exacerb
sle
may
result
catastroph
consequ
patient
patient
sle
appear
increas
risk
infect
due
dysregul
immun
system
usag
immunosuppress
especi
steroid
cyclophosphamid
strongest
risk
factor
infect
patient
sle
increas
flareup
sle
may
reflect
viral
infect
viral
reactiv
ebv
transfusiontransmit
viru
ttv
increas
preval
sle
patient
sle
patient
sometim
may
difficult
distinguish
flare
superimpos
infect
complic
matter
superimpos
infect
lead
flare
sle
parvoviru
cmv
report
caus
induct
sle
flare
infect
parvoviru
mimic
symptom
sle
bacteri
infect
common
caus
infect
sle
account
almost
infect
commonli
identifi
bacteria
includ
staphylococcu
aureu
streptococu
pyogen
streptococcu
pneumonia
escherichia
coli
account
infect
less
commonli
report
bacteria
includ
enterococcu
klebsiella
pseudomona
salmonella
listeria
mycobacterium
tuberculosi
nocardia
critic
circumst
vital
import
distinguish
lupu
flare
infect
elev
dsdna
low
point
toward
flareup
lupu
wherea
leukocytosi
posit
cultur
indic
infect
requir
treatment
antibiot
epsteinbarr
viru
ubiquit
human
dna
viru
infect
b
cell
caus
polyclon
activ
produc
polyclon
antibodi
polyclon
bcell
activ
may
earli
step
pathogenesi
sle
serolog
associ
crossreact
select
ebvspecif
antibodi
sle
autoantigen
slelik
autoimmun
immun
ebv
peptid
increas
eb
viral
load
sle
patient
slespecif
alter
ebv
humor
cellular
immun
implic
ebv
develop
sle
interestingli
preval
ebv
infect
report
high
young
sle
patient
compar
preval
control
similar
result
report
larg
studi
adult
patient
studi
demonstr
adult
sle
seroconvert
ebv
compar
normal
subject
give
odd
ratio
p
peripher
blood
mononuclear
cell
sle
patient
show
greater
express
latent
lytic
gene
infect
suggest
ebv
may
particip
etiolog
sle
sever
differ
mechan
alter
infect
pattern
may
contribut
increas
level
ebv
molecular
mimicri
seen
sera
sle
patient
sever
studi
demonstr
ebv
load
higher
peripher
blood
sle
patient
compar
control
realtim
quantit
pcr
show
signific
increas
amount
ebv
dna
peripher
blood
mononuclear
cell
lupu
patient
compar
control
studi
also
demonstr
abnorm
high
frequenc
ebvinfect
cell
patient
sle
associ
occurr
sle
diseas
flare
aberr
express
viral
lytic
latenc
latenc
membran
protein
gene
also
detect
blood
sle
patient
abnorm
regul
ebv
infect
sle
patient
reflect
sensit
viru
perturb
immun
system
infect
ebv
result
product
viral
protein
ebv
nuclear
antigen
ebna
antibodi
crossreact
lupusassoci
autoantigen
includ
ro
sm
lupu
patient
tabl
region
consider
homolog
compris
highli
charg
residu
grgrgrgrgrgrg
identifi
site
crossreact
compon
sm
tabl
antibodi
direct
capabl
bind
peptid
immun
anim
peptid
induc
product
antibodi
react
sm
patient
antiro
antibodi
develop
first
sequenc
recogn
usual
contain
amino
acid
tkykqrrngwshk
sequenc
crossreact
sequenc
bound
antibodi
lupu
patient
studi
carri
pediatr
sle
patient
demonstr
pediatr
sle
patient
match
normal
individu
make
distinct
antibodi
respons
antibodi
associ
sle
autoantibodi
direct
spliceosom
protein
antism
antinuclear
rnp
found
lupu
patient
sera
possibl
molecular
mimicri
ebv
peptid
pppgrrp
peptid
pppgmrpp
sm
human
spliceosom
consist
possibl
ebv
infect
relat
origin
sle
patient
autoantibodi
mani
patient
sle
bind
sm
autoantigen
polypeptid
bind
serial
serum
specimen
overlap
octapeptid
sm
demonstr
octapeptid
pppgmrpp
pppgirgp
earli
target
autoimmun
respons
lupu
patient
studi
demonstr
rabbit
immun
pppgmrpp
pppgirgp
develop
antibodi
bind
octapeptid
also
subsequ
bind
mani
octapeptid
sm
peptideimmun
anim
develop
featur
sle
antinuclear
antibodi
antism
antibodi
antidoublestrand
dna
thrombocytopenia
seizur
proteinuria
immunogen
use
experi
pppgmrpp
similar
pppgrrp
ebv
also
bound
human
sera
contain
antism
autoantibodi
persist
ebv
infect
patient
sle
may
relat
antiapoptot
potenti
b
cell
due
infect
ebv
primari
infect
autoreact
b
cell
infect
ebv
turn
prolifer
becom
latent
infect
memori
b
cell
resist
apoptosi
occur
normal
bcell
homeostasi
express
virusencod
antiapoptot
molecul
sever
case
report
lupu
associ
human
cmv
hcmv
infect
case
activ
infect
cmv
determin
either
presenc
antihcmv
igm
viral
dna
detect
time
flareup
symptom
lupu
implic
hcmv
possibl
etiolog
agent
lupu
develop
sle
may
trigger
cmv
infect
exist
sle
may
undergo
exacerb
follow
cmv
infect
strike
similar
clinic
featur
hematolog
find
sle
parvoviru
infect
includ
anemia
thrombocytopenia
arthriti
sever
case
report
parvoviru
infect
caus
flareup
sle
parvoviru
may
accompani
transient
subclin
state
autoimmun
may
mimic
exacerb
sle
elev
rheumatoid
factor
antiphospholipid
antilymphocyt
antinuclear
antibodi
frequent
observ
late
phase
infect
occur
peak
viremia
concentr
antibodi
usual
declin
rapidli
within
day
occasion
autoimmun
respons
persist
may
associ
manifest
arthriti
vascul
fibromyalgia
parvoviru
may
properti
induc
product
autoimmun
antibodi
mimick
autoantigen
turn
may
contribut
exacerb
symptom
sle
deplet
erythroid
progenitor
cell
apoptosi
chronic
parvoviru
infect
associ
product
wide
array
autoantibodi
transfusiontransmit
viru
recent
discov
viru
extrem
high
genet
divers
commonli
infect
human
sle
patient
produc
autoantibodi
human
endogen
retroviru
encod
nuclear
protein
possibl
molecular
mimicri
ttv
highest
preval
crossreact
shown
residu
ttv
peptid
preval
ttv
note
increas
sle
patient
respect
healthi
control
dysregul
apoptosi
occur
hiv
sle
patient
hiv
infect
caus
shift
helper
th
cytokin
profil
similar
found
patient
sle
nef
tat
gene
thought
mediat
shift
cytokin
product
tcell
declin
mediat
increas
rate
apoptosi
program
cell
death
cytokin
protect
apoptosi
wherea
cell
increas
rate
apoptosi
shift
cell
caus
acceler
apoptosi
sle
patient
anemia
leucopenia
thrombocytopenia
polymyos
vascul
occur
sle
hiv
patient
observ
suggest
common
mechan
mediat
increas
apoptosi
autoantibodi
product
sle
aid
may
indic
sle
probabl
caus
viru
yet
identifi
turn
sle
thought
mediat
cell
remit
patient
infect
tat
protein
hiv
induc
oxid
stress
increas
surfac
express
fa
ligand
result
acceler
signal
fa
pathway
figur
addit
cleavag
hiv
proteas
may
expos
cell
varieti
apoptot
signal
figur
endogen
retrovir
sequenc
repres
link
viral
genet
factor
may
influenc
develop
sle
endogen
retrovir
element
encod
kda
nuclear
autoantigen
express
tissuespecif
manner
antibodi
detect
patient
sle
overlap
syndrom
sever
laboratori
compar
normal
donor
hivinfect
patient
repres
singl
copi
element
per
haploid
genom
map
common
fragil
site
chromosom
region
one
least
ten
chromosom
loci
shown
independ
studi
link
develop
sle
presenc
absenc
polymorph
hindiii
site
defin
two
differ
allel
form
genom
locu
comparison
normal
blood
donor
differenti
segreg
polymorph
genotyp
locu
ie
rel
decreas
genotyp
increas
genotyp
iii
note
among
patient
sle
region
chromosom
found
contain
suscept
gene
confer
risk
sle
multipl
ethnic
group
support
notion
anoth
gene
close
link
may
influenc
suscept
sle
kd
protein
first
lupu
autoantigen
shown
contain
region
homolog
immunolog
crossreact
gag
protein
mammalian
type
c
retrovirus
mimick
epitop
anoth
lupu
autoantigen
sm
gag
defin
base
crossreact
monoclon
antibodi
prolinerich
domain
present
subunit
sm
hiv
gag
suggest
core
crossreact
epitop
antibodi
bind
gag
found
patient
sle
show
similar
ttv
protein
lupu
sera
strong
bind
affin
peptid
show
similar
retrovir
gaglik
region
kd
snrnp
lupu
autoantigen
suggest
crossreact
ttv
kd
snrnp
may
lead
epitop
spread
contribut
gener
antinuclear
antibodi
regul
belong
famili
small
gtpase
regul
receptor
endosom
recycl
regul
express
may
play
activ
role
lifecycl
support
fact
coordin
upregul
downregul
express
hivinfect
cell
pbmc
promot
activ
protein
level
increas
cell
infect
transfect
hivtat
turn
enhanc
express
may
contribut
downregul
recycl
cell
surfac
thu
prevent
reinfect
allow
increas
virion
product
protect
virusinfect
cell
kill
cytotox
cell
thu
stimul
express
regul
hiv
coreceptor
recycl
repres
novel
mechan
coordin
interact
infecti
viral
particl
endogen
retrovirus
human
genom
express
low
lupu
cell
express
high
rais
possibl
role
viru
similar
hiv
sle
altern
genet
factor
may
contribut
increas
express
sle
role
repair
exonucleas
autoimmunitydetect
nucleic
acid
induct
type
ifn
princip
element
antivir
defenc
result
autoimmun
misregul
cytosol
dna
detect
activ
potent
cell
intrins
antivir
respons
poorli
defin
pathway
call
ifnstimulatori
dna
isd
pathway
essenti
regul
isd
respons
delin
genet
pathway
link
defici
lethal
autoimmun
identifi
isd
induc
neg
regul
isd
respons
mutat
human
gene
caus
aicardigoutier
syndrom
chilblain
lupu
stetson
et
al
demonstr
singlestrand
dna
deriv
endogen
retro
element
accumul
cell
metabol
reversetranscrib
dna
new
mechan
autoimmun
defect
metabol
intracellular
nucleic
acid
trigger
cellintrins
autoimmun
respons
suggest
contribut
endogen
retro
element
autoimmun
type
c
oncorna
virus
postul
associ
sle
lymphoblastoid
cell
line
deriv
patient
activ
sle
allow
spontan
transform
peripher
b
lymphocyt
b
cell
harbor
endogen
ebv
super
infect
peripher
lymphocyt
exogen
ebv
extens
studi
conduct
search
type
c
oncorna
virus
use
electron
microscopi
dnadna
hybrid
revers
transcriptas
assay
cocultiv
experi
reveal
neg
result
result
experiment
studi
role
type
c
virus
sle
conflict
sever
report
increas
viral
express
attempt
type
c
viru
isol
tissu
sle
patient
unsuccess
increas
antibodi
measl
parainfluenza
type
detect
patient
sle
three
possibl
explan
observ
first
could
reflect
persist
viral
infect
second
increas
antibodi
level
might
nonspecif
result
immunolog
hyperreact
final
increas
antibodi
may
due
antigen
share
host
cell
viru
molecular
mimicri
vaccin
associ
onset
flareup
sle
total
five
healthi
patient
receiv
immun
combin
vaccin
includ
typhoid
influenza
meningococc
vaccin
tetanu
toxoid
measl
mump
rubella
vaccin
anthrax
vaccin
develop
sle
week
secondari
immun
trigger
onset
sle
may
either
bacteri
viral
compon
vaccin
chemic
compon
solvent
adjuv
sever
case
report
suggest
tempor
relat
sle
hepat
b
vaccin
causal
relationship
yet
proven
studi
safeti
efficaci
hbv
patient
wellestablish
lupu
report
suggest
link
influenza
vaccin
lupu
isol
rare
associ
efficaci
safeti
influenza
vaccin
lupu
patient
proven
sever
studi
isra
cohort
studi
patient
sle
vaccin
pneumococc
vaccin
show
chang
biolog
clinic
marker
diseas
activ
month
vaccin
hungarian
cohort
studi
sle
patient
show
good
toler
pneumococc
vaccin
preval
incid
lupu
high
patient
certain
ethnic
group
sle
common
hispan
origin
african
descent
north
america
caribbean
background
uk
asian
descent
india
pakistan
china
well
countri
around
pacif
includ
north
american
indian
australian
aborigin
new
zealand
maori
hispan
africanamerican
africancaribbean
south
asian
chines
tend
present
sle
younger
age
renal
involv
earlier
damag
often
higher
mortal
caucasian
system
lupu
erythematosu
rare
west
africa
common
central
southern
africa
increas
frequenc
toward
west
includ
caribbean
europ
america
one
possibl
explan
malaria
common
west
africa
immun
respons
malaria
may
act
protect
factor
prevent
sle
africanamerican
usa
origin
west
africa
increas
incid
sle
group
could
explain
fact
protect
effect
malaria
recent
studi
indic
genet
factor
may
increas
risk
seriou
infect
sle
mannosebind
lectin
mbl
one
molecul
lectin
complement
activ
pathway
share
mani
featur
human
mbl
deriv
singl
gene
locat
chromosom
patient
mbl
defici
associ
homozyg
mbl
variant
allel
report
increas
risk
infect
patient
sle
homozyg
mbl
variant
allel
fourfold
increas
incid
infect
report
low
serum
mbl
predispos
chines
sle
patient
infect
especi
bacteri
infect
presenc
antimbl
autoantibodi
sera
sle
patient
influenc
mbl
plasma
level
function
activ
least
third
sle
patient
defici
also
suffer
recurr
bacteri
infect
includ
otiti
media
meningitid
pneumonia
increas
suscept
bacteri
infect
may
present
defici
individu
occur
mainli
infanc
childhood
transcript
factor
express
b
cell
dendrit
cell
regul
express
varieti
gene
lead
induct
ifn
proinflammatori
cytokin
mice
defici
gene
product
type
ifn
viral
infect
decreas
impair
induct
proinflammatori
cytokin
tlr
stimul
human
overexpress
stimul
express
type
ifn
gene
viral
infect
knockdown
short
interf
rna
reduc
induct
type
ifn
respons
ligand
variant
gene
encod
signal
transduc
activ
transcript
also
discov
risk
factor
sle
identif
risk
gene
support
hypothesi
type
ifn
pathway
play
key
role
pathogenesi
sle
h
infect
pseudomona
aeruginosa
mice
show
impair
product
proinflammatori
cytokin
macrophag
inflammatori
thu
appear
contribut
pseudomona
aeruginosainduc
inflamm
necessari
bacteri
clearanc
two
new
suscept
loci
sle
identifi
chromosom
itgamitgax
gene
encod
x
chromosom
gene
like
involv
within
two
loci
blk
b
lymphoid
tyrosin
kinas
itgam
tabl
hygien
hypothesi
postul
infect
may
protect
autoimmun
diseas
epidemiolog
evid
indic
alarm
increas
autoimmun
diseas
last
three
decad
north
america
europ
thought
link
improv
socioeconom
statu
better
hygien
specif
reduc
microbi
exposur
children
result
western
lifestyl
howev
immunolog
chang
induc
higher
standard
hygien
childhood
still
debat
two
possibl
explan
includ
miss
immun
deviat
caus
reduc
product
polar
cytokin
cell
innat
immun
respons
stimul
tlr
microbi
compon
reduc
activ
tregulatori
cell
caus
reduc
stimul
immun
system
studi
demonstr
northsouth
gradient
distribut
autoimmun
diseas
incid
autoimmun
diseas
decreas
north
south
northern
hemispher
reciproc
south
north
southern
hemispher
infect
european
countri
may
distribut
accord
southnorth
gradient
mirror
imag
gradient
autoimmun
diseas
consist
observ
autoimmun
diseas
suscept
strain
mice
rat
develop
earlier
higher
rate
among
anim
bred
specif
pathogenfre
environ
among
anim
bred
convent
environ
similar
effect
use
pathogenfre
condit
report
rat
collageninduc
arthriti
experiment
model
rheumatoid
arthriti
figur
bacteria
virus
could
protect
autoimmun
diseas
effect
tlr
tlr
receptor
variou
bacteri
compon
serv
receptor
peptidoglycan
bacteri
lipoprotein
gramneg
lipopolysaccharid
flagellin
cpg
motif
bacteri
dna
tlr
bind
bacteri
ligand
stimul
mononuclear
cell
produc
cytokin
turn
could
downregul
autoimmun
respons
anim
studi
demonstr
toxoplasma
gondii
infect
may
prevent
develop
lupuslik
syndrom
autoimmun
new
zealand
black
white
nzbw
mice
pathogen
isotyp
antidna
antibodi
serum
gondiiinfect
mice
significantli
reduc
level
antiself
heatshock
protein
igg
autoantibodi
sera
nzbw
mice
significantli
higher
control
mice
week
gondii
infect
furthermor
nzbw
mice
treat
monoclon
antibodi
substanti
protect
onset
glomerulonephr
addit
downregul
intracellular
express
shown
spleen
cell
gondiiinfect
nzbw
mice
result
indic
gondii
infect
capabl
prevent
develop
autoimmun
renal
disord
nzbw
mice
helicobact
pylori
infect
may
play
protect
role
develop
sle
immunoregulatori
event
lead
h
pylori
seroposit
correl
invers
risk
develop
sle
suggest
fact
associ
sle
hpylori
seroneg
discuss
previous
sle
rare
west
africa
common
central
southern
africa
increas
frequenc
toward
west
includ
caribbean
europ
america
one
possibl
explan
malaria
common
west
africa
act
protect
factor
develop
sle
africanamerican
origin
west
africa
increas
incid
sle
popul
could
also
explain
fact
consider
genet
admixtur
sinc
arriv
america
sever
mechan
postul
malaria
protect
develop
autoimmun
diseas
sle
malaria
potent
induc
tumor
necrosi
factor
tnf
known
patholog
malaria
result
initi
induct
cytokin
patient
infect
plasmodium
falciparum
high
level
tnf
higher
risk
develop
sever
form
diseas
cerebr
malaria
tnfinduc
activ
macrophag
neutrophil
control
parasit
replic
earli
stage
malaria
uncontrol
overproduct
cytokin
lead
sever
diseas
consequ
reduc
abil
gener
tnf
low
endem
area
malaria
greater
risk
develop
autoimmun
diseas
sle
like
explan
higher
rate
sle
africanamerican
anoth
mechan
describ
defunct
sleassoci
polymorph
inhibitori
receptor
african
asian
popul
correspond
area
malaria
endem
mice
increas
clearanc
malari
parasit
develop
less
sever
diseas
defici
dysfunct
associ
develop
autoimmun
especi
sle
mice
human
vaccin
may
two
role
develop
autoimmun
diseas
may
induc
autoimmun
prevent
onset
infect
may
protect
role
develop
autoimmun
diseas
probabl
unlik
sinc
infect
implic
develop
autoimmun
diseas
protect
vaccin
second
postul
vaccin
may
contribut
develop
autoimmun
diseas
stimul
immun
system
repeat
inject
vaccin
along
adjuv
bacillu
calmett
guerin
bcg
vaccin
q
fever
vaccin
evalu
children
prevent
diabet
popul
children
risk
develop
diseas
difficulti
encount
vaccin
given
repeat
interv
isol
immun
stimul
suffici
produc
protect
mechan
obtain
experiment
model
suscept
sle
depend
cumul
interact
mani
genet
loci
contain
polymorph
variant
likelihood
develop
diseas
function
number
suscept
gene
present
genom
individu
locu
chromosom
breach
immunolog
toler
chromatin
anoth
locu
chromosom
trigger
gener
bcell
hyperact
locu
chromosom
associ
number
tcell
aberr
mediat
myeloid
cell
genet
polymorph
delet
within
diminish
abrog
viral
bind
receptor
lead
lower
suscept
infect
slower
diseas
progress
person
carri
mutat
mice
suscept
locu
demonstr
enhanc
antibacteri
respons
especi
pneumonia
intraabdomin
sepsi
compar
wildtyp
mice
associ
markedli
increas
accumul
neutrophil
infect
tissu
neutrophil
lupussuscept
mice
display
markedli
reduc
rate
apoptosi
associ
alter
express
famili
protein
lead
greater
accumul
hand
inhibit
apoptosi
wildtyp
mice
increas
accumul
neutrophil
site
infect
result
enhanc
antibacteri
respons
observ
suggest
genet
loci
mediat
autoimmun
may
also
produc
enhanc
antibacteri
immun
viral
infect
induc
product
larg
amount
turn
modul
immun
respons
produc
posit
effect
stimul
cell
mediat
autoimmun
howev
produc
neg
respons
immunoregulatori
properti
util
treatment
multipl
sclerosi
may
also
protect
role
develop
autoimmun
diseas
demonstr
anim
model
experiment
allerg
encephalomyel
lesser
extent
human
autoimmun
diseas
rheumatoid
arthriti
summari
infect
play
major
role
modul
develop
autoimmun
diseas
perform
dual
role
protect
also
induct
diseas
process
underli
mechan
multipl
extrem
complex
vari
wide
accord
specif
pathogen
involv
studi
role
infect
develop
protect
autoimmun
diseas
extrem
difficult
sever
possibl
explan
difficulti
identifi
infect
etiolog
agent
autoimmun
diseas
one
hypothesi
long
lag
time
initi
causal
infect
onset
clinic
symptom
sle
caus
infect
may
resolv
quickli
serolog
evid
may
disappear
time
clinic
onset
autoimmun
diseas
evid
emerg
studi
human
sle
role
autoimmun
tlr
signal
cell
lead
product
cytokin
b
cell
cell
prolifer
differenti
immunoglobulin
switch
genet
defici
may
confer
protect
autoimmun
murin
sle
delet
may
enhanc
diseas
activ
pharmacolog
modul
tlr
signal
may
offer
new
therapeut
target
treatment
sle
sever
studi
progress
may
futur
identifi
virus
bacteria
etiolog
agent
lupu
expand
therapeut
perspect
sle
form
antiinfecti
agent
treatment
sle
vaccin
could
use
prevent
diseas
onset
sle
implic
virus
major
role
includ
epsteinbarr
viru
retrovirus
parvoviru
play
less
signific
role
includ
transfusiontransmit
viru
cytomegaloviru
paramyxoviru
anim
studi
suggest
toxoplasma
gondii
may
protect
role
develop
autoimmun
diseas
serum
gondiiinfect
nzbw
mice
pathogen
isotyp
antidna
antibodi
significantli
reduc
level
antiself
heatshock
protein
igg
autoantibodi
significantli
higher
sera
downregul
intracellular
express
spleen
cell
nzbw
mice
infect
gondii
helicobact
pylori
may
protect
role
develop
autoimmun
diseas
sinc
seroposit
h
pylori
shown
decreas
risk
develop
system
lupu
erythematosu
sle
epidemiolog
studi
suggest
infect
malaria
act
protect
factor
develop
sle
vaccin
may
dual
role
develop
autoimmun
diseas
provid
protect
prevent
infect
contribut
autoimmun
diseas
repeat
inject
vaccin
adjuv
isol
case
report
flareup
sle
secondari
administr
hepat
b
vaccin
influenza
vaccin
chang
serolog
marker
pneumococc
vaccin
chromosom
sle
chromosom
perhap
critic
lupu
suscept
loci
identifi
mous
model
lupu
genet
loci
mediat
autoimmun
may
also
produc
enhanc
antibacteri
immun
increas
product
coincid
diseas
flare
may
proinflammatori
protect
effect
product
may
reflect
viral
infect
viral
reactiv
infect
predispos
pathogenesi
sle
induc
flare
also
mimic
flare
sle
meticul
exclus
infect
improv
detect
infecti
agent
import
patient
sle
sinc
masquerad
exacerb
sle
use
immunosuppress
presenc
infect
lead
disastr
consequ
innat
immunityrel
receptor
signal
molecul
could
becom
therapeut
target
treatment
sle
need
identifi
infect
induc
lupu
anim
prove
infect
etiolog
factor
pathogenesi
sle
futur
studi
requir
evalu
antiinfecti
agent
treatment
sle
vaccin
prevent
measur
onset
sle
virus
influenc
adapt
immun
molecular
mimicri
ie
homolog
exogen
endogen
epitop
peptid
sequenc
common
viru
eg
ebv
protein
target
lupu
autoantigen
eg
sm
induc
autoantibodi
hiv
tat
upregul
produc
function
mimicri
ebv
protein
regul
apoptosi
make
protein
also
exampl
function
mimicri
ebv
epsteinbarr
viru
ttv
transfusiontransmit
viru
cell
recogn
pamp
use
pathogen
recognit
receptor
tlr
necrot
debri
apoptot
pathway
bacteri
lipopolysaccharid
viral
rna
viral
dna
act
tlr
plasmacytoid
dendrit
cell
produc
type
ifn
import
host
defens
virus
overproduct
ifn
system
lupu
erythematosu
tlr
activ
plasmacytoid
dendrit
cell
lead
releas
result
matur
antigen
present
cell
augment
tcell
activ
includ
excess
helper
activ
natur
killer
cell
produc
signific
amount
cytokin
exampl
influenc
develop
cell
ifn
interferon
pamp
pathogenassoci
molecular
pattern
tlr
tolllik
receptor
infecti
agent
lead
pathogenesi
sle
sever
mechan
includ
molecular
mimicri
apoptosi
program
cell
death
hand
infect
malaria
act
protect
agent
vaccin
may
act
protect
agent
prevent
infect
induc
sle
may
also
protect
effect
sle
system
lupu
erythematosu
oxid
ultraviolet
light
corticosteroid
trigger
apoptosi
damag
mitochondria
turn
lead
caspas
activ
factor
process
inhibit
viral
homolog
releas
roi
caus
increas
product
fa
ligand
dna
fragment
tat
increas
mitochondri
roi
product
therebi
increas
apoptosi
tat
protein
induc
oxid
stress
increas
surfac
express
fa
ligand
result
acceler
signal
fa
pathway
roi
reactiv
oxygen
intermedi
int
j
clin
rheumtol
author
manuscript
avail
pmc
decemb
